[ad_1]
WASHINGTON (Reuters) – Finasteride, a drug used to fight male pattern baldness, may protect against the risk of prostate cancer, researchers at the University of Texas at the University of Texas have discovered.
The drug used by US President Donald Trump to combat baldness, according to his doctor during an interview with the New York Times, offers a safe and economical option to help protect men from the fatal illness. The researchers found that the drug, marketed under the brand name Propecia, could give hope to thousands of men by protecting it from 25% against the risk of prostate cancer.
"Finasteride is safe, inexpensive and effective as a preventative strategy against prostate cancer," said Dr. Ian Thompson of the SWOG Cancer Network, USA. The experiment, which began 25 years ago, involved some 20,000 men, making it one of the largest prostate cancer trials ever done. According to New England, fewer than 100 men who participated in the prostate cancer prevention trial died of this disease. Dr. Thompson said that doctors should inform patients of the benefits of this drug, especially those who undergo regular screening tests for prostate specific antigen (PSA).
[ad_2]
Source link
